Fatty Acid Supplementation and Retinopathy of Prematurity
This secondary analysis of a randomized clinical trial examines what risk factors for retinopathy of prematurity are influenced by supplementation with arachidonic acid and docosahexaenoic acid and their interactions with severe retinopathy of prematurity.
Authors
- Anders Nilsson (ORCID: https://orcid.org/0000-0003-3631-0783)
- Staffan Nilsson
- Peter Lundgren (ORCID: https://orcid.org/0000-0003-0500-4070)
- Aldina Pivodic (ORCID: https://orcid.org/0000-0002-2224-3236)
- Lois E. H. Smith
- Ann Hellström
Institutions
- Boston Children's Hospital (US)
- Harvard University (US)
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1001/jamaophthalmol.2025.5994
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00